[Management of chronic hemodialysis patients with anemia: case study conducted in the Department of Nephrology and Hemodialysis at the University Hospital Point G in Mali].

INTRODUCTION

Anemia is a frequent complication of Chronic Kidney Disease CKD commonly found in chronic haemodialysis patients. Patients management is mainly based on erythropoietin administration and iron supplementation. This study aimed to evaluate the management of chronic hemodialysis patients with anemia in the Department of Nephrology and Hemodialysis at the University Hospital Point G in Mali.

METHODS

We conducted a cross-sectional study from 1 to 31 August 2016.

RESULTS

63 patients out of a total of 174 participants were selected, 34 men and 29 women with a sex-ratio of 1.17 in favor of men. The average age of patients was 48,79 years ±11.59, the average duration of hemodialysis treatment time was 3,77years±2.6. Hospitalization rate for anemia in our dialysis patients was 84,12%. 92.1% of patients required blood transfusion, with an annual average of 5,81 blood bags ±5.91. 87.3% of cases required iron supplementation. Mean ferritin concentration and TSC were 1245 ng/ml±629,52 and 46,16%±19.12 respectively. Occasional administration of EPO doses not exceeding the 4000IU was reported by 79.4% of patients. The main difficulty in using EPO was its cost (74.6%). HCV infection was found in 60.1% of patients who were assessed.

CONCLUSION

The management of chronic dialysis patients with anemia should be integrated into the framework of the national health policy.